Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 15 Dec 2004

Bober Sharon L, Hoke Lizbeth A, Duda Rosemary B, Regan Meredith M, Tung Nadine M

Abstract excerpt

PURPOSE: To explore the health-related and psychological factors that influence decision making about tamoxifen (Nolvadex; AstraZeneca, Waltham, MA) chemoprevention in women at increased risk for developing breast cancer. METHODS: This study involves the assessment of 129 women eligible to take tamoxifen following cancer-risk counseling. Treatment decision and decision satisfaction were measured at 2 and 4 months...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Chemoprevention

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Counseling

Share to Decision Making

Share to Medical History Taking

Share to Patient Education as Topic

Share to Physician-Patient Relations

Share to Tamoxifen

Source

Identifiers

PMID: 15598980
DOI: 10.1200/JCO.2004.05.192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.PMID 15598980Read ↗

Breast cancer prevention: patient decision making and risk communication in the high risk setting.Semantic proximity Read ↗

Decision making after BRCA genetic testing. Down the road of transition.Semantic proximity Read ↗

Risk-reduction mastectomy: clinical issues and research needs.Semantic proximity Read ↗

Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.Semantic proximity Read ↗

Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.Semantic proximity Read ↗

Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.Semantic proximity Read ↗

Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.Semantic proximity Read ↗

Patients' resistance to risk information in genetic counseling for BRCA1/2.Semantic proximity Read ↗

Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.Semantic proximity Read ↗

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Mammography decision making in older women with a breast cancer family history.Semantic proximity Read ↗

Breast cancer in young women: clinical decision-making in the face of uncertainty.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.